<?xml version="1.0" encoding="UTF-8"?>
<p>The activation of dormant LSCs and deactivation of proliferating LSCs are described by rate constants 
 <italic>p
  <sub>XY</sub>
 </italic> and 
 <italic>pYX</italic> respectively. LSCs proliferate with a rate constant 
 <italic>p</italic>. During therapy, a cytotoxic TKI effect acts on proliferating LSCs, described by the rate 
 <italic>e
  <sub>TKI</sub>
 </italic>&gt;0. Differentiation of proliferating LSCs is quantified by 
 <italic>p
  <sub>W</sub>
 </italic> and the limited life-time of differentiated LCs is modeled by a mortality rate 
 <italic>r
  <sub>W</sub>
 </italic>. We define a net leukemia reduction 
 <inline-formula>
  <math id="mm5">
   <mrow>
    <mi>q</mi>
    <mo>=</mo>
    <msub>
     <mi>e</mi>
     <mrow>
      <mi>T</mi>
      <mi>K</mi>
      <mi>I</mi>
     </mrow>
    </msub>
    <mo>−</mo>
    <msub>
     <mi>p</mi>
     <mi>Y</mi>
    </msub>
   </mrow>
  </math>
 </inline-formula>with 
 <italic>q</italic>&gt;0 for effective treatment. For illustrating simulations we used parameter values corresponding to the median values of the selected patients (
 <italic>Online Supplementary Text S1–S3</italic>). Reimplementation of the model in a stochastic version using a Gillespie algorithm ensured that there are no distinct differences resulting from small cell numbers (
 <italic>Online Supplementary Text S4</italic>).
</p>
